CGNX

Insider trade Sale by Long Darren Marc (Vice President)

4d ago

News Cognex (CGNX) Q2 Revenue Rises 4%

14d ago

News Meet the Supercharged Growth Stock That Could Make You a Millionaire

14d ago

News Here's Why Cognex Stock Slumped in August (and Why It's a Buying Opportunity)

14d ago

News Why Artificial Intelligence (AI) Stock Cognex Crashed More Than 20% Today

14d ago

News Tesla's Resurgence Is Great News for These 3 Growth Stocks - The Motley Fool

14d ago

News Analyst Expectations For Cognex's Future

14d ago

News Is ProShares S&P Technology Dividend Aristocrats ETF (TDV) a Strong ETF Right Now?

14d ago

News Wall Street Just Turned Bullish on This Hot Technology Stock: Time to Buy?

14d ago

Insider trade Sale by Mark Fennell (Chief Legal Officer &Secretary)

20d ago

Insider trade Sale by Laura Ann Macdonald (VP and PAO)

20d ago

Insider trade Sale by Laura Ann Macdonald (VP and PAO)

20d ago

News Cognex forecasts Q2 revenue $280M-$300M with 28%-31% adjusted EBITDA margin, while targeting $35M-$40M net cost reductions by end-2026

26d ago

Insider trade Sale by Dianne M Parrotte

90d ago

Insider trade Sale by Robert Willett

104d ago

Insider trade Sale by Laura Ann Macdonald (VP and PAO)

104d ago

Insider trade Sale by Robert Willett

104d ago

News Activist investor Engaged Capital boosts its stake in BRC

131d ago

News Cognex Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates

138d ago

News Novartis Cosentyx® meets primary and all secondary endpoints in Phase III trial in patients with polymyalgia rheumatica (PMR)

153d ago

News Novartis Cosentyx Trial Shows Efficacy In Patients With Stiff Joints And Muscle Pain

153d ago

News Nvidia Up on AI Licensing Deal, Biohaven Down on Study Results, Coforge Up

158d ago

News Coforge to Buy Encora At $2.35 Billion EV Through Share Swap

158d ago